Orchard Therapeutics plc Quarterly Depreciation in USD from Q1 2018 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Orchard Therapeutics plc annual/quarterly Depreciation history and growth rate from Q1 2018 to Q1 2022.
  • Orchard Therapeutics plc Depreciation for the quarter ending March 31, 2022 was $600K, a 20% increase year-over-year.
  • Orchard Therapeutics plc Depreciation for the twelve months ending March 31, 2022 was $2.3M, a 14% increase year-over-year.
  • Orchard Therapeutics plc annual Depreciation for 2022 was $2.4M, a 9.09% increase from 2021.
  • Orchard Therapeutics plc annual Depreciation for 2021 was $2.2M, a 10% increase from 2020.
  • Orchard Therapeutics plc annual Depreciation for 2020 was $2M, a 19.4% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $2.3M $600K +$100K +20% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.2M $700K +$282K +67.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $1.92M $500K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $1.92M $500K -$100K -16.7% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $2.02M $500K +$18K +3.73% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2M $418K -$191K -31.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.19M $500K +$200K +66.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.99M $600K +$200K +50% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.79M $482K +$116K +31.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.68M $609K +$336K +123% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $1.34M $300K -$100K -25% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $1.44M $400K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.44M $366K +$240K +190% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.2M $273K Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $400K Jul 1, 2018 Sep 30, 2018 6-K 2019-11-07
Q2 2018 $400K Apr 1, 2018 Jun 30, 2018 6-K 2019-08-08
Q1 2018 $126K Jan 1, 2018 Mar 31, 2018 6-K 2019-05-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.